Intrathecal release of nitric oxide and its relation to final brain damage in patients with stroke

Cerebrovascular Diseases

Volumn 10, Issue 3, 2000, Pages 200-206

  Tarkowski, E ^a,b   Ringqvist, A ^a   Rosengren, L ^a   Jensen, C ^a   Ekholm, S ^a   Wennmalm, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Rheumatology ^*  (Sweden)

Author keywords

Apoptosis; Cytokines; Magnetic resonance imaging; Nitric oxide

Indexed keywords

CYTOKINE; FAS ANTIGEN; NITRATE; NITRIC OXIDE; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE;

EID: 0034005885     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016057     Document Type: Article

References (38)

1. Siesjö BK: A new perspective on ischemic brain damage? Prog Brain Res 1993;9:1-12.
2. Diemer NH, Valente E, Bruhn T, Berg M, Jörgensen MB, Johansen FF: Glutamate receptor transmission and ischemic nerve cell damage: Evidence for involvement of excitotoxic mechanisms. Prog Brain Res 1993;96:105-124.
3. Watson BD: Evaluation of the concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke. Prog Brain Res 1993;96:69-96.
4. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367-1379.
5. Hallenbeck JM, Dutka AJ: Background review and current concept of reperfusion injury. Arch Neurol 1990;47:1245-1254.
6. Schroeter M, Jander S, Witte OW, Stoll G: Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 1994;55:195-203.
7. Wang X, Yue T-L, Barone FC, Feuerstein GZ: Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke 1995;26:1665-1669.
8. Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg M-J, Kaste M: Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996;94:939-945.
9. Shiga Y, Onodera H, Kogure K, Yamasaki Y, Yashima Y, Syozyhara H, Sendo F: Neutrophil as mediator of ischemic edema formation in the brain. Neurosci Lett 1991;125:110-112.
10. Gross CE, Howard DB, Dooley RH, Raymond SJ, Fuller S, Bednar MM: TGF-β1 posttreatment in a rabbit model of cerebral ischaemia. Neurol Res 1994;16:465-470.
11. Relton JK, Rothwell N: Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992;29:243-246.
12. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: A cytotoxic activated macrophage molecule. Biochem Biophys Res Commun 1988;157:87-94.
13. Simmons M, Murphy S: Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 1993;5:828-831.
14. Iadecola C, Zhang F, Xu X: Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 1995;268: R286-R292.
15. Zhang F, White JG, Iadecola C: Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: Evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 1994;14: 217-226.
16. Zhang F, Iadecola C: Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J Cereb Blood Flow Metab 1994;14:574-580.
17. Dalkara T, Moskowitz MA: Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischemia; in Green AR, Cross AJ (eds): Neuroprotective Agents and Cerebral Ischemia, IRN 40. New York, Academic Press, 1997, pp 319-336.
18. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
19. Meldrum BS: The role of nitric oxide in ischemic damage; in Siesjö BK, Wieloch T (eds): Advances in Neurology. Philadelphia, Lippincott-Raven, 1996, vol 71: Cellular and Molecular Mechanisms of Ischemic Brain Damage, pp 355-363.
20. Pelligrino DA: Saying NO to cerebral ischemia. J Neurosurg Anesthesiol 1993;5(4):221-231.
21. Tarkowski E, Rosenbren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-1398.
22. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro- and antiinflammatory cytokines in stroke. Clin Exp Immunol 1997; 110:492-499.
23. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Stroke 1985; 16:885-890.
24. Mahoney FI, Barthel DW: Functional evaluation: The Barthel Index. Md Med J 1965;24: 61-69.
25. Hachinski V: Classification of stroke for clinical trials. Stroke 1990;21:27-29.
26. Blomstrand C, Olsson JE, Nilsson B, von Arbin M, Britton M, Elwin CE, Elmers C, Norrving B, Rosen A, Samuelsson K, Strandberg K, Wahlgren NG: Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991;338:1345-1349.
27. Tarkowski E, Rosengren L, Blomstrand C, Jensen C, Ekholm S, Tarkowski A: Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 1999;30:321-327.
28. Ringqvist A, Leppert J, Myrdal U, Ahlner J, Ringqvist J, Wennmalm A: Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects. Clin Physiol 1997;17:269-277.
29. Landorp PM, Aarden LA, Calafat J, Zeijlemaker WP: A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986; 132:105-113.
30. Aarden LA, de Groot ER, Shaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17: 1411-1416.
31. Helle M, Boeije L, Aarden LA: Functional discrimination between interleukin-6 and interleukin-1. Eur J Immunol 1988;18:1535-1540.
32. Kretschmann H-J, Weinrich V: Cranial neuroimaging and clinical anatomy, ed 2. Stuttgart, Thieme, 1992, pp 1-100.
33. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, Nathorst Westfelt U, Petersson A-S, Waagstein F: Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993;73:1121-1127.
34. Malinski T, Bailey F, Zhang ZG, Chopp M: Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 1993;13:355-358.
35. Kader A, Frazzini VI, Solomon RA, Trifileti RR: Nitric oxide production during focal cerebral ischemia. Stroke 1993;24:1709-1716.
36. Zhang ZG, Chopp M, Gautam S, Zaloga C, Chang RL, Schmidt HW, Pollock JS, Fostermann U: Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurones after focal cerebral ischaemia in rat. Brain Res 1994; 654:85-95.
37. Iadecola C, Zhang F, Xu S, Casey R, Ross ME: Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995;15:378-384.
38. Zhang F, Casey R, Ross ME, Iadecola C: Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 1996;27:317-323.